BRAF mutational status is associated with survival outcomes in locally advanced resectable and metastatic NSCLC
Por:
Provencio M, de Lope L, Serna-Blasco R, Nadal E, Tain P, Massuti B, Gonzalez-Larriba J, Insa A, Sanchez-Hernandez A, Casal-Rubio J, Garcia-Campelo R, Lopez S, Rogado J, Martinez-Marti A, Bosch-Barrera J, Bernabe R, Estevez S, Ponce S, de Castro J, Sarto J, Reguart N, Domine M, Aguilar A, Majem M, Estival A, Cabia S, Martin A, Gonzalez M, Cobo M, Camps C, Barneto I, Calvo V, Collazo-Lorduy A, Cruz-Bermudez A, Romero A
Publicada:
1 ago 2024
Ahead of Print:
1 jun 2024
Resumen:
|